Iryna Ivanchuk
Biographic Data
| ID | 7449033 |
|---|---|
| NAME | Iryna Ivanchuk |
| GIVEN NAMES | Iryna |
| FAMILY NAME | Ivanchuk |
| SIGNATURE | IVANCHUK I |
| AFFILIATIONS | Ministry of Health |
| ORCID | 0009-0001-9969-8650 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Initiation, retention, and discontinuation of extended-release buprenorphine (BUP-XR) for opioid dependence
Effectiveness of Self-Help plus and problem management plus interventions in providing psychological support to clients of Opioid Agonist treatment programs in Ukraine
Background The paper presents an effectiveness study of two World Health Organization (WHO) scalable psychological interventions, Self-Help Plus (SH+) and Problem Management Plus (PM+), for the patients of the Opioid Agonist Treatment (OAT) programs in Ukraine during wartime. Method The study (pragmatic trial) was designed as an experiment with two intervention groups (for SH+ and PM+) and one control group (waiting list). The GAD-7, PHQ-9, LEC-5…
Treatment of opioid use disorder in Ukraine during the first year of the Russia–Ukraine war
No prominent works on this page.
Treatment of opioid use disorder in Ukraine during the first year of the Russia–Ukraine war
Effectiveness of Self-Help plus and problem management plus interventions in providing psychological support to clients of Opioid Agonist treatment programs in Ukraine
Background The paper presents an effectiveness study of two World Health Organization (WHO) scalable psychological interventions, Self-Help Plus (SH+) and Problem Management Plus (PM+), for the patients of the Opioid Agonist Treatment (OAT) programs in Ukraine during wartime. Method The study (pragmatic trial) was designed as an experiment with two intervention groups (for SH+ and PM+) and one control group (waiting list). The GAD-7, PHQ-9, LEC-5…
Initiation, retention, and discontinuation of extended-release buprenorphine (BUP-XR) for opioid dependence
HIV, Drug Use, Sexual Risk (2 works) · Mental Health Treatment and Access (2 works) · Migration, Health and Trauma (2 works) · Opioid (2 works) · Adverse effect (1 work) · Buprenorphine (1 work) · Business (1 work) · Clinical trial (1 work) · Depression (economics (1 work) · Discontinuation (1 work)